Samir Ranjan Panda

Dr. Samir Ranjan Panda

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PSPritam Saha
Pritam Saha
SDSneha Durugkar
Sneha Durugkar
SJSiddhi Jain
Siddhi Jain
PSP. A. Shantanu
P. A. Shantanu
SPSamir Ranjan Panda
Samir Ranjan Panda
VNVGM Naidu
VGM Naidu
Piperine (PIP) is a major phytoconstituent in black pepper which is responsible for various pharmacological actions such as anti-inflammatory, antioxidant, and antitumor activity. To investigate the effects and mechanisms of PIP on cigarette smoke (CS)-induced lung pathology using both in-vitro and in-vivo models. BEAS-2B and A549 cells were exposed to CS extract (CSE) for 48 h; BALB/c mice were exposed to CS (9 cigarettes/day, 4 days) to induce features of airway disease. PIP at doses of (0.25, 1.25, and 6.25 µM, in vitro; 1 and 10 mg/kg, in vivo, i.n) and DEX (1 µM, in vitro; 1 mg/kg, in vivo, i.n) were used to assess cytotoxicity, oxidative stress, epithelial–mesenchymal transition (EMT), Sirtuin1 (SIRT1), inflammation-related cellular signaling, and lung function. PIP treatment protects cells from CSE-induced lung epithelial cell death. PIP treatment restores the epithelial marker (p < 0.05) and decreases the mesenchymal, inflammatory markers (p < 0.05) in both in vitro and in vivo models. The PIP treatment improves the altered lung function (p < 0.05) in mice induced by CS exposure. Mechanistically, PIP treatment modulates SIRT1 thereby reducing the inflammatory markers such as IL-1β, IL-6 and TNF-α (p < 0.05) and enhancing the epigenetic marker HDAC2 (p < 0.05) and antioxidant marker Nrf2 (p < 0.05) expressions. Thus, PIP alleviates pulmonary inflammation by modulating the SIRT1-mediated inflammatory cascade, inhibits EMT, and activates Nrf2 signaling.

1 December 2021 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
MKMohit Kwatra
Mohit Kwatra
Sahabuddin AhmedSahabuddin Ahmed
Sahabuddin Ahmed
VGVijaya Kumar Gangipangi
Vijaya Kumar Gangipangi
SPSamir Ranjan Panda
Samir Ranjan Panda
NGNitika Gupta
Nitika Gupta
VNV.G.M. Naidu
V.G.M. Naidu

7 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
PYPrasanna Anjaneyulu Yakkala
Prasanna Anjaneyulu Yakkala
SPSamir Ranjan Panda
Samir Ranjan Panda
SSSyed Shafi
Syed Shafi
VNVGM Naidu
VGM Naidu
MYMohammad Yar
Mohammad Yar
AKAhmed Kamal
Ahmed Kamal
A series of new 1,2,4-triazolo-linked bis-indolyl conjugates (15a–r) were prepared by multistep synthesis and evaluated for their cytotoxic activity against various human cancer cell lines. It was observed that they were more susceptible to colon and breast cancer cells. Conjugates 15o (IC50 = 2.04 μM) and 15r (IC50 = 0.85 μM) illustrated promising cytotoxicity compared to 5-fluorouracil (5-FU, IC50 = 5.31 μM) against the HT-29 cell line. Interestingly, 15o and 15r induced cell cycle arrest at the G0/G1 phase and disrupted the mitochondrial membrane potential. Moreover, these conjugates led to apoptosis in HT-29 at 2 μM and 1 μM, respectively, and also enhanced the total ROS production as well as the mitochondrial-generated ROS. Immunofluorescence and Western blot assays revealed that these conjugates reduced the expression levels of the PI3K-P85, β-catenin, TAB-182, β-actin, AXIN-2, and NF-κB markers that are involved in the β-catenin pathway of colorectal cancer. The results of the in silico docking studies of 15r and 15o further support their dual inhibitory behaviour against PI3K and tankyrase. Interestingly, the conjugates have adequate ADME-toxicity parameters based on the calculated results of the molecular dynamic simulations, as we found that these inhibitors (15r) influenced the conformational flexibility of the 4OA7 and 3L54 proteins.

12 February 2025 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
SPSamir Ranjan Panda
Samir Ranjan Panda
PPPallabi Panja
Pallabi Panja
MSMeenakshi Singh
Meenakshi Singh
USUjjawal Soni
Ujjawal Soni
BRBishal Rajdev
Bishal Rajdev
VNVGM Naidu
VGM Naidu

3 March 2021
Verified
Book Chapter
Open access
PDF file
MKMohit Kwatra
Mohit Kwatra
Sahabuddin AhmedSahabuddin Ahmed
Sahabuddin Ahmed
SPSamir Ranjan Panda
Samir Ranjan Panda
VNVGM Naidu
VGM Naidu
NGNitika Gupta
Nitika Gupta
Muscles are the enriched reservoir of proteins in the body. During any workout or exercise, the demand in the form of energy is essentially required by the muscle. Energy expenditure of skeletal muscle is more dependent on the type of demand. There is particular homeostasis within the body that avoid surplus energy expenditure and this prevents any muscle loss. Muscle atrophy is termed as the loss of skeletal muscle mass due to immobility, malnutrition, medications, aging, cancer cachexia, variety of injuries or diseases that impact the musculoskeletal or nervous system. Hence, atrophy within the skeletal muscle initiates further cause fatigue, pain, muscle weakness, and disability in human subjects. Therefore, starvation and reduced muscle mass further initiate numerous signaling pathways including inflammatory, antioxidant signaling, mitochondria bio-energetic failure, AMP-activated protein kinase (AMPK), Sirtuin 1(SIRT1), BDNF/TrkB/PKC, Autophagy, ubiquitin-proteasome systems, etc. Here, in this chapter, we will mention molecular mechanisms involved in therapeutic targets and available Pharmacological Interventions with the latest updates.

24 April 2026 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
SPSamir Ranjan Panda
Samir Ranjan Panda
USUjjawal Soni
Ujjawal Soni
PPPallabi Panja
Pallabi Panja
BRBishal Rajdev
Bishal Rajdev
MSMeenakshi Singh
Meenakshi Singh
VNVGM Naidu
VGM Naidu